Sumagoc, Gellier D.

HRN: 29-39-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/31/2026
08/07/2026
IV
2.25gm
Q6h
CAP HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: